Skip to main content
NYSE:IVA

Inventiva News Headlines

$14.20
+0.05 (+0.35 %)
(As of 05/14/2021 12:00 AM ET)
Add
Compare
Today's Range
$14.20
$14.48
50-Day Range
$13.00
$15.14
52-Week Range
$9.01
$19.06
Volume10,557 shs
Average Volume31,331 shs
Market Capitalization$548.55 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Inventiva (NYSE IVA) News Headlines Today

SourceHeadline
Inventiva (NYSE:IVA) Sees Strong Trading VolumeInventiva (NYSE:IVA) Sees Strong Trading Volume
americanbankingnews.com - May 14 at 11:32 AM
INVENTIVA: Inventiva reports first quarter 2021 financial information and updates on the collaboration with AbbVie in auto-immune diseasesINVENTIVA: Inventiva reports first quarter 2021 financial information and updates on the collaboration with AbbVie in auto-immune diseases
finanznachrichten.de - May 12 at 5:57 PM
Inventiva reports first quarter 2021 financial information and updates on the collaboration with AbbVie in auto-immune diseasesInventiva reports first quarter 2021 financial information and updates on the collaboration with AbbVie in auto-immune diseases
finance.yahoo.com - May 12 at 5:57 PM
Inventiva (NYSE:IVA) Shares Gap Down to $14.76Inventiva (NYSE:IVA) Shares Gap Down to $14.76
americanbankingnews.com - May 4 at 12:16 PM
Inventiva (NYSE:IVA) Receives "Buy" Rating from Roth CapitalInventiva (NYSE:IVA) Receives "Buy" Rating from Roth Capital
americanbankingnews.com - May 4 at 12:16 PM
Inventiva (NYSE:IVA) Sees Large Volume IncreaseInventiva (NYSE:IVA) Sees Large Volume Increase
americanbankingnews.com - April 21 at 11:06 AM
INVENTIVA: Appointment of Martine Zimmermann as Independent Director to Inventivas Board of DirectorsINVENTIVA: Appointment of Martine Zimmermann as Independent Director to Inventiva's Board of Directors
finanznachrichten.de - April 19 at 6:20 PM
Appointment of Martine Zimmermann as Independent Director to Inventiva’s Board of DirectorsAppointment of Martine Zimmermann as Independent Director to Inventiva’s Board of Directors
finance.yahoo.com - April 19 at 6:20 PM
Results of the votes of the Combined Shareholders’ Meeting of April 16, 2021Results of the votes of the Combined Shareholders’ Meeting of April 16, 2021
finance.yahoo.com - April 19 at 1:20 PM
El escritor César Aira ganó el Premio Formentor 2021El escritor César Aira ganó el Premio Formentor 2021
msn.com - April 13 at 1:44 PM
La ironía lúdica e imaginativa del escritor argentino César Aira conquista el Premio Formentor 2021La ironía lúdica e imaginativa del escritor argentino César Aira conquista el Premio Formentor 2021
msn.com - April 13 at 1:44 PM
Inventiva S.A. (IVA.PA)Inventiva S.A. (IVA.PA)
in.finance.yahoo.com - March 11 at 7:39 AM
INVENTIVA: 2020 Full-Year Results: Major advances in NASH and significantly extended cash runway through successful IPO in the United StatesINVENTIVA: 2020 Full-Year Results: Major advances in NASH and significantly extended cash runway through successful IPO in the United States
finanznachrichten.de - March 4 at 6:20 PM
INVENTIVA: Inventiva announces collaboration on non-invasive biomarkers to identify patients responding to lanifibranor withINVENTIVA: Inventiva announces collaboration on non-invasive biomarkers to identify patients responding to lanifibranor with
bloomberg.com - February 25 at 6:27 PM
Inventiva S.A. - American Depository SharesInventiva S.A. - American Depository Shares
benzinga.com - December 13 at 12:47 AM
INVENTIVA: Inventiva to participate at the Piper Sandler 32nd Annual Virtual Healthcare ConferenceINVENTIVA: Inventiva to participate at the Piper Sandler 32nd Annual Virtual Healthcare Conference
finanznachrichten.de - November 26 at 10:02 PM
INVENTIVA: Inventiva receives positive FDA feedback to advance its lead drug candidate lanifibranor into pivotal Phase III in NASHINVENTIVA: Inventiva receives positive FDA feedback to advance its lead drug candidate lanifibranor into pivotal Phase III in NASH
finanznachrichten.de - November 11 at 3:13 PM
INVENTIVA: Inventiva to participate at the Stifel Virtual Healthcare Conference 2020 and the 11th Jefferies Virtual Healthcare ConferenceINVENTIVA: Inventiva to participate at the Stifel Virtual Healthcare Conference 2020 and the 11th Jefferies Virtual Healthcare Conference
finanznachrichten.de - November 9 at 5:32 PM
Inventiva to participate at the Stifel Virtual Healthcare Conference 2020 and the 11th Jefferies Virtual Healthcare ConferenceInventiva to participate at the Stifel Virtual Healthcare Conference 2020 and the 11th Jefferies Virtual Healthcare Conference
finance.yahoo.com - November 9 at 5:32 PM
INVENTIVA: Inventiva announces the appointment of Dr. Michael Cooreman as Chief Medical OfficerINVENTIVA: Inventiva announces the appointment of Dr. Michael Cooreman as Chief Medical Officer
finanznachrichten.de - November 5 at 6:10 PM
INVENTIVA: Inventiva announces the additional acceptance of two late-breaking abstracts at the AASLD The Liver Meeting Digital Experience 2020INVENTIVA: Inventiva announces the additional acceptance of two late-breaking abstracts at the AASLD The Liver Meeting Digital Experience 2020
finanznachrichten.de - November 3 at 12:30 AM
Inventiva announces the publication of a scientific paper on the role of PPARs in the treatment of NASH in the medical journal Nature Review Gastroenterology & HepatologyInventiva announces the publication of a scientific paper on the role of PPARs in the treatment of NASH in the medical journal Nature Review Gastroenterology & Hepatology
finance.yahoo.com - November 2 at 7:29 PM
Inventiva S.A Rings The Nasdaq Stock Market Closing BellInventiva S.A Rings The Nasdaq Stock Market Closing Bell
nasdaq.com - October 29 at 7:00 PM
INVENTIVA: Inventiva to host a Key Opinion Leader webcast from the AASLD The Liver Meeting Digital Experience 2020INVENTIVA: Inventiva to host a Key Opinion Leader webcast from the AASLD The Liver Meeting Digital Experience 2020
finanznachrichten.de - October 28 at 6:37 PM
Inventiva S.A Rings the Closing BellInventiva S.A Rings the Closing Bell
nasdaq.com - October 28 at 6:37 PM
Inventiva to host a Key Opinion Leader webcast from the AASLD The Liver Meeting Digital Experience™ 2020Inventiva to host a Key Opinion Leader webcast from the AASLD The Liver Meeting Digital Experience™ 2020
finance.yahoo.com - October 28 at 6:37 PM
Inventivas odiparcil nabs accelerated review in U.S. for a rare genetic disorderInventiva's odiparcil nabs accelerated review in U.S. for a rare genetic disorder
seekingalpha.com - October 20 at 8:56 AM
INVENTIVA: Inventiva receives FDA Fast Track designation in MPS VI for its clinical-stage asset odiparciINVENTIVA: Inventiva receives FDA Fast Track designation in MPS VI for its clinical-stage asset odiparci
finanznachrichten.de - October 19 at 6:49 PM
Inventiva receives FDA Fast Track designation in MPS VI for its clinical-stage asset odiparciInventiva receives FDA Fast Track designation in MPS VI for its clinical-stage asset odiparci
finance.yahoo.com - October 19 at 6:49 PM
INVENTIVA S.A.(PROM.)-,01 (6IV.MU)INVENTIVA S.A.(PROM.)-,01 (6IV.MU)
ca.finance.yahoo.com - October 18 at 6:19 PM
Inventiva S.A. Actions Nom.(Pro (6IV.SG)Inventiva S.A. Actions Nom.(Pro (6IV.SG)
ca.finance.yahoo.com - October 17 at 9:01 AM
Inventiva S.A. ADRInventiva S.A. ADR
barrons.com - October 15 at 6:58 PM
INVENTIVA: Inventiva receives FDA Breakthrough Therapy designation for lead drug candidate lanifibranor in NASHINVENTIVA: Inventiva receives FDA Breakthrough Therapy designation for lead drug candidate lanifibranor in NASH
finanznachrichten.de - October 12 at 9:10 PM
Inventiva nabs Breakthrough Device tag for its lead candidate for NASHInventiva nabs Breakthrough Device tag for its lead candidate for NASH
seekingalpha.com - October 12 at 9:10 PM
Inventiva selected to present the results of its NATIVE Phase IIb clinical trial with lanifibranor in NASH during a plenary session at The Liver Meeting Digital Experience™ 2020Inventiva selected to present the results of its NATIVE Phase IIb clinical trial with lanifibranor in NASH during a plenary session at The Liver Meeting Digital Experience™ 2020
finance.yahoo.com - October 7 at 2:31 PM
INVENTIVA: Inventiva to participate at several investor conferences in October 2020INVENTIVA: Inventiva to participate at several investor conferences in October 2020
finanznachrichten.de - September 24 at 2:09 PM
Inventiva to participate at several investor conferences  in October 2020Inventiva to participate at several investor conferences in October 2020
finance.yahoo.com - September 24 at 2:09 PM
Inventiva SA to Host Earnings CallInventiva SA to Host Earnings Call
finance.yahoo.com - September 17 at 7:34 AM
Inventiva reports 1H resultsInventiva reports 1H results
seekingalpha.com - September 16 at 9:04 PM
H1 2020 financial results and  corporate business updateH1 2020 financial results and corporate business update
finance.yahoo.com - September 16 at 9:04 PM
INVENTIVA: Inventiva to participate at several investor conferences in September 2020INVENTIVA: Inventiva to participate at several investor conferences in September 2020
finanznachrichten.de - September 9 at 2:55 PM
Inventiva to participate at several investor conferences in September 2020Inventiva to participate at several investor conferences in September 2020
finance.yahoo.com - September 9 at 2:55 PM
Inventiva SACAInventiva SACA
bloomberg.com - August 22 at 7:27 AM
INVENTIVA: Inventiva announces the filing of an amended registration statement, including an estimated initial public offeringINVENTIVA: Inventiva announces the filing of an amended registration statement, including an estimated initial public offering
bloomberg.com - August 14 at 7:49 PM
INVENTIVA: Inventiva announces trading resumption of its ordinary shares on Euronext ParisINVENTIVA: Inventiva announces trading resumption of its ordinary shares on Euronext Paris
bloomberg.com - August 14 at 2:49 PM
INVENTIVA: Inventiva announces the closing of $107.7 million initial public offering on the Nasdaq Global MarketINVENTIVA: Inventiva announces the closing of $107.7 million initial public offering on the Nasdaq Global Market
bloomberg.com - August 14 at 2:49 PM
Half-Year Review of Inventiva’s Liquidity Contract with Kepler CheuvreuxHalf-Year Review of Inventiva’s Liquidity Contract with Kepler Cheuvreux
finance.yahoo.com - August 12 at 3:08 PM
DESCRIPTION OF THE SHARE BUYBACK PROGRAM & RESUMPTION OF THE LIQUIDITY CONTRACTDESCRIPTION OF THE SHARE BUYBACK PROGRAM & RESUMPTION OF THE LIQUIDITY CONTRACT
finance.yahoo.com - August 10 at 8:33 PM
DESCRIPTION OF THE SHARE BUYBACK PROGRAM & RESUMPTION OF THE LIQUIDITY CONTRACTDESCRIPTION OF THE SHARE BUYBACK PROGRAM & RESUMPTION OF THE LIQUIDITY CONTRACT
finance.yahoo.com - August 10 at 3:32 PM
Inventiva SA American Depositary Share Repr Shs BuyInventiva SA American Depositary Share Repr Shs Buy
markets.businessinsider.com - August 7 at 8:11 AM
This page was last updated on 5/16/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.